Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood

Bone Marrow Transplantation

Volumn 26, Issue 12, 2000, Pages 1281-1290

  Kato, S ^a   Yabe, H ^a   Yasui, M ^b   Kawa, K ^b   Yoshida, T ^c   Watanabe, A ^d   Osugi, Y ^e   Horibe, K ^f   Kodera, Y ^g  

^a TOKAI UNIVERSITY   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^c TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^d AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

Allogeneic hematopoietic stem cell transplantation; CD34; Graft failure; GVHD; Relapse

Indexed keywords

CD34 ANTIGEN; HLA ANTIGEN;

ACUTE DISEASE; ADOLESCENT; ALLOGRAFT; ARTICLE; BENIGN TUMOR; BLOOD; BONE MARROW; CELL SELECTION; CHILD; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DONOR; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HLA SYSTEM; HUMAN; INCIDENCE; INFECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; NEUTROPHIL; OUTCOMES RESEARCH; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROBABILITY; RELAPSE; SURVIVAL; THROMBOCYTE;

ACTUARIAL ANALYSIS; ACUTE DISEASE; ANTIGENS, CD34; BLOOD CELLS; BLOOD DONORS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; FOLLOW-UP STUDIES; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0034487763     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702707     Document Type: Article

References (45)

1. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cells
2. Isolation of a candidate human hematopoietic stem-cell population
3. + cells engraft lethally irradiated baboons
4. + marrow cells, devoid of T and B lymphocyte, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons
5. + marrow cells in patients with breast cancer or neuroblastoma
6. + blood cells
7. Successful engraftment of allogeneic CD34-enriched marrow cell transplantation from HLA-mismatched parental donors
8. + progenitor cells from matched related donors
9. + peripheral blood stem cells in patients with advanced hematologic malignancy
10. + selected cells from peripheral blood
11. + progenitor cell transplantation from HLA-mismatched family members to 21 children with high risk disorders
12. + progenitor cell transplantation from two HLA-mismatched healthy fathers to two infants with severe aplastic anemia
13. + cells from HLA-mismatched donors
14. + cells from peripheral blood: Experience of 62 cases using immunoadsorption of immunomagnetic technique
15. Treatment of high-risk acute leukemia with T cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
16. A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation
17. Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor
18. + blood cells in leukemia or lymphoma patients at high risk of GVHD
19. + progenitors for autologous and allogeneic transplantation in children
20. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts
21. A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation
22. Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation
23. Successful engraftment of T cell-depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood to bone marrow inoculum
24. Graft failure following HLA-matched T-lymphocyte depleted bone marrow transplantation
25. T cell depletion of HLA-identical transplants in leukemia
26. The place of blood stem cells in allogeneic transplantation
27. Allogeneic peripheral blood stem transplantation for haematological malignancies - An analysis of kinetics of engraftment and GVHD risk
28. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study
29. Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation
30. Peripheral blood stem cell transplantation from unrelated donors: A comparison with marrow transplantation
31. Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: Influence of stem cell source on outcome
32. Outcomes among 562 recipients of placental-blood transplants from unrelated donors
33. + selection systems or CAMPATH-1
34. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation
35. + cells from HLA-mismatched donors
36. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
37. + selected grafts with recipients of unmanipulated grafts
38. - low/negative hematopoietic stem cell
39. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable level of CD34 antigen exist in multiple species
40. + bone marrow cells
41. + by murine hematopoietic stem cells
42. + cells
43. A newly discovered class of human hematopoietic cells with SCID-repopulating activity
44. Hematopietic stem cells: Are they CD34-positive or CD34-negative?
45. - hematopoietic cells